Raluca Budiu-Predoiu

Company: Abbvie

Job title: Director, Precision Medicine

Seminars:

ctDNA in Metastatic Settings to Assess Progression & Molecular Responses for the Identification of High-Risk Patients 12:45 pm

How ctDNA is used for progression and identifying high risk patients that will progress further than others in the metastatic setting? How to implement ctDNA surrogate biomarkers in clinical trials? What is the best assay to assess the molecular response in metastatic setting? How to harmonize the generation of data across the industry to do…Read more

day: Day Two